Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine-Reference-Cited by-同舟云学术

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine

Published:1997-11 Issue:9091 Volume:350 Page:1569-1577
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Olin Patrick,Rasmussen Finn,Gustafsson L,Hallander Hans O,Heijbel Harald

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Clinical efficacy, immunogenicity and safety of two acellular and one whole-cell pertussis vaccines: results from the Italian trial;Greco;N Engl J Med,1996

2. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine;Gustafsson;N Engl J Med,1996

3. New developments with pertussis vaccines;Halsey;Pediatrics,1995

4. Acellular pertussis vaccines for infants;Edwards;N Engl J Med,1996

5. Accelular pertussis vaccines: new vaccines for an old disease;Poland;Lancet,1996

Cited by 282 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections;npj Vaccines;2024-09-01

2. Genome-based prediction of cross-protective, HLA-DR-presented epitopes as putative vaccine antigens for multiple Bordetella species;Microbiology Spectrum;2024-01-11

3. Reverse vaccinology;Molecular Medical Microbiology;2024

4. Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: a randomised, double-blind, non-inferiority trial;2023-12-22

5. Antibody and B-cell Immune Responses Against Bordetella Pertussis Following Infection and Immunization;Journal of Molecular Biology;2023-12